Physician profile
Mark W Galland
NPI 1689741894
$12,293.79
in general payments reported to CMS, 2019-2025
5 companies · $7,685 in 2025
The $7,685 reported for 2025 was more than what 85% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,893 · 2020: $66.99 · 2021: $1,422 · 2022: $1,200 · 2023: $13.23 · 2024: $13.75 · 2025: $7,685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,750 · Travel and Lodging: $722 · Food and Beverage: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,750.00 |
| Travel and Lodging | $721.96 |
| Food and Beverage | $240.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Moximed, INC | $7,685.32 | 2025 | Misha Knee System, Small, Left |
| Southtech Orthopedics | $3,400.00 | 2019-2022 | |
| Arthrex, INC. | $1,114.50 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $66.99 | 2020 | |
| Depuy Synthes Sales INC. | $26.98 | 2023-2024 | Orthovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Galland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.